We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.81%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$32.7B
AUM Growth
+$3.39B
(+12%)
Cap. Flow
+$2.02B
Cap. Flow
% of AUM
6.18%
Top 10 Holdings %
Top 10 Hldgs %
20.34%
Holding
1,273
New
114
Increased
570
Reduced
394
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$437M |
| 2 |
Intuit
INTU
|
+$333M |
| 3 |
Mastercard
MA
|
+$203M |
| 4 |
Booking.com
BKNG
|
+$186M |
| 5 |
Alibaba
BABA
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$290M |
| 2 |
Akamai
AKAM
|
+$278M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$264M |
| 4 |
Cognizant
CTSH
|
+$252M |
| 5 |
Acuity Brands
AYI
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.14% |
| 2 | Financials | 16.99% |
| 3 | Healthcare | 14.67% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Lockheed Martin
LMT
$119B
| $9.32M | 0.03% |
33,567
+1,996
| +6% | +$548K |
|
327
Omnicom Group
OMC
$22.6B
| $9.31M | 0.03% |
112,329
+2,065
| +2% | +$172K |
|
|
FFKT
328
DELISTED
Farmers Capital Bank Corp
FFKT
| $9.27M | 0.03% |
240,433
+5,661
| +2% | +$225K |
|
329
iShares Core MSCI Emerging Markets ETF
IEMG
$153B
| $9.23M | 0.03% |
184,549
+94,114
| +104% | +$4.64M |
|
|
TYPE
330
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $9.17M | 0.03% |
501,187
-181,295
| -27% | -$3.55M |
|
331
TechnipFMC
FTI
$29.9B
| $9.17M | 0.03% |
453,089
+361,112
| +393% | +$8.14M |
|
332
Medtronic
MDT
$105B
| $8.95M | 0.03% |
100,832
+29,000
| +40% | +$2.45M |
|
333
Dollar General
DG
$26.5B
| $8.78M | 0.03% |
121,732
+2,258
| +2% | +$163K |
|
334
Clarus
CLAR
$129M
| $8.55M | 0.03% |
1,291,377
-60,721
| -4% | -$357K |
|
335
Invesco QQQ Trust
QQQ
$469B
| $8.47M | 0.03% |
61,533
+160
| +0.3% | +$22K |
|
336
Emerson Electric
EMR
$78.2B
| $8.46M | 0.03% |
141,837
-1,204
| -0.8% | -$71.4K |
|
337
Donaldson
DCI
$10.5B
| $8.43M | 0.03% |
185,202
+120
| +0.1% | +$5.53K |
|
338
Paychex
PAYX
$39.4B
| $8.38M | 0.03% |
147,160
+87,504
| +147% | +$5.14M |
|
339
WisdomTree Japan Hedged Equity Fund
DXJ
$7.21B
| $8.31M | 0.03% |
159,770
+51,337
| +47% | +$2.63M |
|
340
ConocoPhillips
COP
$145B
| $8.29M | 0.03% |
188,477
-1,014
| -0.5% | -$47.3K |
|
341
Coherus Oncology
CHRS
$221M
| $8.08M | 0.02% |
562,810
+111,274
| +25% | +$2.14M |
|
342
Arthur J. Gallagher & Co
AJG
$62.3B
| $8.02M | 0.02% |
140,143
+160
| +0.1% | +$9.04K |
|
|
WFC.WS
343
DELISTED
Wells Fargo & Company Ws
WFC.WS
| $8.02M | 0.02% |
361,048
| – | – |
|
344
Vanguard Value ETF
VTV
$187B
| $7.96M | 0.02% |
82,412
+2,349
| +3% | +$225K |
|
|
CBPO
345
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $7.95M | 0.02% |
70,276
+33,771
| +93% | +$3.77M |
|
346
Kimberly-Clark
KMB
$36.1B
| $7.94M | 0.02% |
61,465
+2,214
| +4% | +$288K |
|
347
Dominion Energy
D
$62.5B
| $7.91M | 0.02% |
103,243
-284
| -0.3% | -$22.3K |
|
348
Deere & Co
DE
$164B
| $7.91M | 0.02% |
63,986
-607
| -0.9% | -$71.2K |
|
349
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.74B
| $7.89M | 0.02% |
116,973
-5,435
| -4% | -$357K |
|
|
SNC
350
DELISTED
State National Companies, Inc.
SNC
| $7.88M | 0.02% |
+428,398
| New | +$6.86M |
|
Similar funds
QCM
Brown Advisory's Q2 2017 Portfolio in Review
As of Q2 2017, Brown Advisory held 1,273 positions worth $32.7B, up 12% from $29.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Brown Advisory deployed $2.02B of net new capital in Q2 2017, opening 114 new positions and adding to 570 existing holdings. Its largest new stake was Altaba Inc: 2,311,186 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $290M trimmed.
- Brown Advisory's largest Q2 2017 buy was Altaba Inc: 2,311,186 shares worth $126M.
- Brown Advisory added most to Zoetis in Q2 2017, an estimated $437M increase.
- Brown Advisory's biggest Q2 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $290M.
- Brown Advisory fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $264M.
- Brown Advisory's ten largest holdings make up 20% of its $32.7B portfolio in Q2 2017.
- Brown Advisory opened 114 new positions and closed 56 in Q2 2017.
- Brown Advisory's portfolio value rose 12% quarter-over-quarter to $32.7B.
Based on Brown Advisory's 13F filing for Q2 2017, filed 14 Aug 2017.